• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
    • About Us
    • Founding Team
  • Blog
  • Drug Search
  • Zones
    • Suicide
    • Violence
    • Sex and Relationships
    • Hair
    • Skin and Nails
    • Withdrawal
    • Vision
    • Fertility
  • Research Fund
  • Tools
    • Healthcare Record Pro Forma
    • Starting a Medication
    • Guides & Papers
    • Too Many Medications?
    • Complex Withdrawal
    • Videos
    • Reducing the Risk of Treatment Induced Suicide
  • PSSD
    • Post-SSRI Sexual Dysfunction (PSSD)
    • PSSD Doctors
    • PSSD Literature
    • PSSD in the Media
    • RxISK Prize
    • Research Forum for Enduring Sexual Dysfunction
  • Side Effect?
RxISK Logo

RxISK

Making Medicines Safer for All of Us

Drug Search by Year (Detail)

Side effect search by year (detail)

Drug:

Reaction: HAEMORRHAGE

20250101 - 20251231

No. 101 - 200

Next page: 3 next page>>
No.
safetyreportid
occurcountry
patientonsetage
patientsex 1:M 2:F
Adverse reaction
Drug (openfda.generic_name, medicinalproduct)
101
25136042
US
15 2
Haemorrhage,
INSULIN LISPRO,
102
25136709
US
2
Pneumonia, COVID-19, Haemorrhage, Influenza, Product use issue,
APIXABAN, METOPROLOL TARTRATE, METOPROLOL, INSULIN GLARGINE, DEXMEDETOMIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, LEVETIRACETAM, METHYLPREDNISOLONE SODIUM SUCCINATE, ERGOCALCIFEROL, GUAIFENESIN, LEVOTHYROXINE SODIUM, SPIRONOLACTONE, MAGNESIUM, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM,
103
25136996
GB
2
Illness, Haemorrhage,
TIRZEPATIDE,
104
25137035
US
38 1
Haemorrhage,
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL,
105
25137036
US
19 1
Haemorrhage,
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL,
106
25137064
US
1
Colostomy, Haemorrhage, Hepatic enzyme increased,
UPADACITINIB,
107
25137124
UY
16 2
Retinal artery occlusion, Acne, Faecal calprotectin decreased, Haemorrhage, Rash, Fear,
UPADACITINIB, UPADACITINIB,
108
25126470
US
59 1
Haemorrhage,
INSULIN GLARGINE,
109
25126476
US
57 2
Haemorrhage,
INSULIN LISPRO, INSULIN GLARGINE,
110
25126911
US
82 1
Haemorrhage, Off label use,
BIMEKIZUMAB, BIMEKIZUMAB,
111
25127290
GR
Drug-induced liver injury, Off label use, Bacterial infection, Deep vein thrombosis, Acute kidney injury, Acute coronary syndrome, Haemorrhage, Arrhythmia,
TOCILIZUMAB, BARICITINIB,
112
25127374
US
24 1
Haemorrhage,
INSULIN LISPRO,
113
25127771
US
31 2
Laparotomy, Haemorrhage, Device breakage, Foreign body in reproductive tract, Complication of device removal, Pelvic inflammatory disease, Ovarian abscess, Emotional disorder, Cystitis, Pain, Abnormal uterine bleeding,
COPPER,
114
25127969
CN
67 2
Altered state of consciousness, Subdural haematoma, Intracranial mass, Haemorrhage, Condition aggravated,
CLOPIDOGREL BISULFATE,
115
25128009
US
60 2
Haemorrhage,
INSULIN LISPRO,
116
25128656
US
50 1
Haemorrhage,
117
25128658
US
46 1
Haemorrhage, Pain,
118
25128822
BR
Haemorrhage, Drug ineffective,
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA,
119
25129027
US
75 1
Haemorrhage,
INSULIN LISPRO, INSULIN GLARGINE,
120
25129306
US
1
Haemorrhage, Tooth disorder,
EMICIZUMAB,
121
25129337
US
55 2
Haemorrhage,
INSULIN LISPRO, INSULIN GLARGINE,
122
25129340
US
32 1
Haemorrhage,
INSULIN LISPRO, INSULIN GLARGINE,
123
25129399
US
Acute hepatic failure, Toxicity to various agents, Arrhythmia, Infection, Septic shock, Gastrointestinal haemorrhage, Haemorrhage, Brain oedema, Seizure, Acute respiratory distress syndrome,
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL,
124
25129528
US
Acute hepatic failure, Toxicity to various agents, Arrhythmia, Infection, Septic shock, Gastrointestinal haemorrhage, Haemorrhage, Brain oedema, Seizure, Acute respiratory distress syndrome,
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL,
125
25129802
VN
3
Haemorrhage,
EMICIZUMAB,
126
25129885
US
22 2
Psoriasis, Haemorrhage, Drug ineffective,
INFLIXIMAB,
127
25129952
US
1 1
Haemorrhage, Head injury, Fall,
128
25130161
US
35 2
Haemorrhage,
INSULIN LISPRO, INSULIN HUMAN,
129
25130216
CA
72 1
Airway remodelling, Microangiopathy, Chronic sinusitis, Ventricular hypokinesia, Memory impairment, Eosinophil count increased, Eosinophilic granulomatosis with polyangiitis, Lymphopenia, Respiratory symptom, Hypertension, Central nervous system mass, Cardiac septal defect, Pneumonia, Respiratory tract infection, Nasal polyps, Atopy, Prostate cancer, Haemorrhage, Eosinophilic myocarditis, Asthma, Eosinophil count decreased, Obesity, Nodule, Haematuria, Confusional state, Blood immunoglobulin E increased, Obstructive airways disorder, Wall motion score index abnormal, Renal disorder, Productive cough, Eosinophilic pneumonia, Viral infection, Lacrimation increased, Condition aggravated,
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CALCIUM, ALBUTEROL SULFATE, ALENDRONATE SODIUM, FOLIC ACID, LANSOPRAZOLE, BEVACIZUMAB, BEVACIZUMAB, BICALUTAMIDE, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, RAMIPRIL, CICLESONIDE, GOSERELIN, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL,
130
25130434
US
56 2
Haemorrhage,
INSULIN LISPRO,
131
25130701
US
72 1
Haemorrhage,
INSULIN LISPRO,
132
25131037
CA
33 2
Abdominal pain, Alopecia, Anorectal disorder, Anxiety, Arthralgia, Attention deficit hyperactivity disorder, Brain fog, Breast pain, Burning sensation, Chills, Cognitive disorder, Drug ineffective, Drug interaction, Dyspepsia, Dysphagia, Dyspnoea, Gastrointestinal pain, Haemorrhage, Headache, Hepatic pain, Hyperhidrosis, Joint swelling, Pain, Paraesthesia, Peripheral swelling, Photosensitivity reaction, Product availability issue, Product formulation issue, Product physical issue, Product shape issue, Product size issue, Product substitution issue, Suspected product tampering, Product taste abnormal, Rash, Rash erythematous, Swelling, Temperature regulation disorder, Therapy interrupted, Tremor, Urinary tract pain, Vaginal disorder, Withdrawal syndrome,
NIRMATRELVIR AND RITONAVIR, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, AMITRIPTYLINE HYDROCHLORIDE, LISDEXAMFETAMINE DIMESYLATE,
133
25131063
US
67 2
Contusion, Haemorrhage,
INSULIN LISPRO, INSULIN DETEMIR,
134
25131252
US
78 2
Discomfort, Haemorrhage, Pain,
INSULIN LISPRO, INSULIN DEGLUDEC,
135
25131253
US
74 1
Haemorrhage,
INSULIN LISPRO, INSULIN GLARGINE,
136
25131307
US
73 2
Haemorrhage,
INSULIN GLARGINE, HUMAN INSULIN,
137
25131309
US
51 2
Haemorrhage,
INSULIN LISPRO,
138
25131380
US
29 2
Haemorrhage,
INSULIN LISPRO, INSULIN GLARGINE,
139
25131462
CN
1
Haemorrhage,
140
25131519
FR
77 2
Confusional state, Agitation, Hallucination, Somnolence, Aggression, Hypokalaemia, Hypophosphataemia, Persecutory delusion, Haemorrhage, Choking, Pulmonary congestion, Head injury, Fall, Encephalopathy, Clostridium difficile colitis,
METHYLPREDNISOLONE, OLANZAPINE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, OXAZEPAM, OXAZEPAM, METHADONE HYDROCHLORIDE, METHADONE, METHADONE HYDROCHLORIDE, METHADONE, MORPHINE SULFATE, APIXABAN, IRBESARTAN, NALOXEGOL OXALATE, LANSOPRAZOLE, AMLODIPINE, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE, BEVACIZUMAB, FLUOROURACIL, FLUOROURACIL, OXALIPLATIN,
141
25131560
US
80 2
Haemorrhage,
INSULIN LISPRO, INSULIN GLARGINE,
142
25131579
US
57 2
Haemorrhage,
INSULIN GLARGINE,
143
25131608
US
76 1
Haemorrhage,
INSULIN LISPRO, INSULIN GLARGINE,
144
25131663
US
81 2
Haemorrhage,
INSULIN LISPRO, INSULIN GLARGINE,
145
25131685
US
69 1
Haemorrhage,
INSULIN GLARGINE,
146
25131860
US
Hypoxia, Arrhythmia, Abdominal pain, Anaemia, Pleural effusion, Hypotension, Dizziness, Dyspnoea, Microcytic anaemia, Gastrooesophageal reflux disease, Haemorrhage,
SELEXIPAG, SELEXIPAG, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, AMBRISENTAN, CEPHALEXIN, TRIMETHOPRIM, WARFARIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL,
147
25131889
US
61 1
Condition aggravated, Myalgia, Haemorrhage,
SECUKINUMAB,
148
25134229
1
Haemorrhage,
DAROLUTAMIDE,
149
25121620
AU
63 1
Haematemesis, Pharyngeal ulceration, Pharyngo-oesophageal diverticulum, Haemorrhage, Epistaxis, Haemoptysis,
CLOPIDOGREL, CLOPIDOGREL BISULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG,
150
25121795
US
52 1
Haemorrhage,
INSULIN LISPRO,
151
25121932
US
29 2
Haemorrhage,
INSULIN LISPRO,
152
25122044
US
77 2
Haemorrhage,
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TADALAFIL, AMBRISENTAN,
153
25122052
US
29 2
Haemorrhage,
INSULIN LISPRO,
154
25122059
US
57 1
Haemorrhage,
INSULIN LISPRO,
155
25122093
US
62 1
Autoimmune arthritis, Adrenal insufficiency, Quadriparesis, Pneumonia parainfluenzae viral, Rib fracture, COVID-19, Intestinal obstruction, Respiratory distress, COVID-19 pneumonia, Neurogenic bowel, Autonomic neuropathy, Impaired gastric emptying, Anaphylactic reaction, Sepsis, Hydronephrosis, Apnoea, Sternal fracture, Adrenocortical insufficiency acute, Pituitary-dependent Cushing^s syndrome, Hypopituitarism, Hypersensitivity, Kyphosis, Diastasis recti abdominis, Upper respiratory tract infection, Upper respiratory tract infection, Bronchitis, Vaccination site pain, Vaccination site erythema, Vaccination site swelling, Chills, Pyrexia, Herpes zoster, Testicular disorder, Abdominal hernia, Lymphadenopathy, Ecchymosis, Haemorrhage, Vitiligo, Heat stroke, Keratoacanthoma, Tooth fracture, Benign prostatic hyperplasia, Drug hypersensitivity, Fatigue, Arthralgia, Myalgia, Wisdom teeth removal, Gait disturbance, Arthralgia, Folate deficiency, Drug ineffective, Compression fracture, Gastrointestinal microorganism overgrowth, Osteoporosis, Asthma, Lower urinary tract symptoms,
ALENDRONATE SODIUM, PREDNISONE, PEMBROLIZUMAB, ADALIMUMAB, ADALIMUMAB, METHOTREXATE, METHOTREXATE SODIUM, ETANERCEPT, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, GOLIMUMAB, INFLIXIMAB,
156
25122129
US
67 2
Haemorrhage,
INSULIN LISPRO, INSULIN DEGLUDEC,
157
25122350
US
70 2
Haemorrhage,
INSULIN GLARGINE,
158
25122546
US
Haemorrhage, Cerebrovascular accident,
VORASIDENIB, BEVACIZUMAB,
159
25122982
US
Haemorrhage,
RELUGOLIX, RELUGOLIX, TALAZOPARIB,
160
25123159
US
47 2
Haemorrhage,
INSULIN LISPRO, SEMAGLUTIDE, INSULIN GLARGINE,
161
25123440
US
45 1
Haemorrhage,
162
25123609
US
60 1
Haemorrhage, Discomfort, Pain,
INSULIN LISPRO, INSULIN GLARGINE,
163
25124172
CA
Drug interaction, Contraindicated product administered, Haemorrhage,
NIRMATRELVIR AND RITONAVIR, RIVAROXABAN,
164
25124356
US
33 2
Haemorrhage, Haematochezia, Dyspnoea, Blood urine present, Dehydration, Fatigue, Gastrointestinal disorder,
FRUQUINTINIB,
165
25124687
CA
2
Haematochezia, Pregnancy, Haemorrhage, Exposure via breast milk,
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, PREDNISONE,
166
25124720
50 2
Haemorrhage, Thrombosis,
LEUPROLIDE ACETATE,
167
25125420
ES
Death, Renal failure, Haemorrhage, Drug intolerance, Infection,
IBRUTINIB,
168
25125867
US
42 2
Haemorrhage,
INSULIN LISPRO, INSULIN DEGLUDEC,
169
25126092
US
85 2
Melaena, Cardiac disorder, Haemorrhage,
APIXABAN, TAFAMIDIS,
170
25126134
JP
Gastric cancer, Intra-abdominal haematoma, Abdominal pain, Haemorrhage,
CLOPIDOGREL, CLOPIDOGREL,
171
25115793
US
46 2
Haemorrhage,
INSULIN LISPRO, TIRZEPATIDE, INSULIN DEGLUDEC,
172
25115898
US
17 1
Haemorrhage,
EMICIZUMAB, EMICIZUMAB,
173
25115996
GB
29 2
Dysmenorrhoea, Haemorrhage,
DAPAGLIFLOZIN, DAPAGLIFLOZIN, LOSARTAN, DAPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG,
174
25116105
US
78 2
Haemorrhage,
INSULIN LISPRO, INSULIN GLARGINE,
175
25116128
US
60 2
Haemorrhage,
INSULIN GLARGINE, INSULIN LISPRO,
176
25116432
US
44 2
Haemorrhage,
INSULIN LISPRO,
177
25116449
US
2
Multiple sclerosis, Fall, Haemorrhage, Scar, Psychiatric symptom, Memory impairment, Pigmentation disorder, Ill-defined disorder,
OFATUMUMAB,
178
25116579
US
11 2
Haemorrhage, Fall,
INSULIN LISPRO,
179
25116625
US
Haemorrhage, Off label use,
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, EMICIZUMAB, EMICIZUMAB,
180
25116779
US
65 2
Haemorrhage,
INSULIN LISPRO,
181
25116784
US
27 1
Haemorrhage,
INSULIN LISPRO,
182
25116786
US
63 1
Haemorrhage,
INSULIN LISPRO, INSULIN GLARGINE,
183
25116952
US
1
Pleural mesothelioma, Exposure to chemical pollution, Shock, Haemorrhage, Pulmonary necrosis, Sepsis,
184
25117056
US
52 2
Haemorrhage,
INSULIN LISPRO, INSULIN ASPART,
185
25117057
US
81 1
Haemorrhage,
INSULIN LISPRO,
186
25117066
US
54 2
Haemorrhage, Skin reaction,
INSULIN LISPRO,
187
25117345
US
89
Haemorrhage, Off label use,
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, EMICIZUMAB,
188
25117457
US
25 1
Haemorrhage,
INSULIN LISPRO, INSULIN GLARGINE,
189
25117465
US
87 1
Haemorrhage,
INSULIN LISPRO,
190
25117473
US
63 1
Haemorrhage,
INSULIN LISPRO,
191
25117897
US
51 1
Haemorrhage, Haemarthrosis,
192
25117973
US
55 2
Haemorrhage,
INSULIN LISPRO, INSULIN GLARGINE,
193
25117977
US
72 2
Haemorrhage,
INSULIN LISPRO, INSULIN GLARGINE,
194
25118422
GR
39 1
Immune thrombocytopenia, Thrombocytopenia, Haemorrhage,
ALEMTUZUMAB, ALEMTUZUMAB,
195
25118576
US
Bronchiectasis, Pulmonary haemorrhage, Bacterial infection, Chronic obstructive pulmonary disease, Wheezing, Therapy cessation, Dyspnoea, Breath odour, Epistaxis, Inflammation, Haemorrhage, Dysphonia, Speech disorder, Amnesia, Asthma,
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE,
196
25118830
GR
48 1
Immune thrombocytopenia, Haemorrhage,
ALEMTUZUMAB, ALEMTUZUMAB,
197
25119981
IT
Death, Glioblastoma, Embolism venous, Embolism arterial, Off label use, Hypertension, Haemorrhage, Proteinuria, Therapeutic product effect incomplete,
BEVACIZUMAB,
198
25120553
US
2
Renal disorder, Urinary tract infection, Full blood count decreased, Vitamin K decreased, Haemorrhage,
ADALIMUMAB,
199
25120621
IT
Thyroid disorder, Skin reaction, Pruritus, Alanine aminotransferase increased, Aspartate aminotransferase increased, Arthritis, Colitis, Nephritis, Proteinuria, Hypertension, Stomatitis, Thrombosis, Gastrointestinal haemorrhage, Haemorrhage, Fatigue, Decreased appetite, Diarrhoea, Neuropathy peripheral, Neoplasm progression,
ATEZOLIZUMAB, BEVACIZUMAB,
200
25120682
GB
61 2
Gastrointestinal haemorrhage, Anal haemorrhage, Haematochezia, Haemorrhage,
TIRZEPATIDE,

disclaimer

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.

terms

https://open.fda.gov/terms/

license

https://open.fda.gov/license/

last_updated

2025-04-28

Next page: 3 next page>>

Primary Sidebar

Recent Posts

  • Withdrawal Syndromes: Lost in Translation
  • Over-Diagnosing or Under-Diagnosing
  • The Future of Health App-ointments
  • Repairing Ruptures in Clinical Care
  • Restoring the Magic to Healthcare

Blog Categories

Footer

Contact

Media Contact

Terms | Privacy

Follow us

  • Facebook
  • Twitter

Search

Copyright © 2025 ยท Data Based Medicine Global Ltd.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok